These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 24356148

  • 21. The prophylactic role for the human papillomavirus quadrivalent vaccine in males.
    Yancey AM, Pitlick JM, Forinash AB.
    Ann Pharmacother; 2010; 44(7-8):1314-8. PubMed ID: 20501891
    [Abstract] [Full Text] [Related]

  • 22. The HPV infection in males: an update.
    Giraldi G, De Luca d'Alessandro E.
    Ann Ig; 2012; 24(6):497-506. PubMed ID: 23234187
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [In defence of women against HPV-infection].
    Blázovics A.
    Orv Hetil; 2007 Apr 29; 148(17):813. PubMed ID: 17452313
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [The vaccines anti-HPV today in the treatment of the genital infections to HPV].
    Gondry J.
    Ann Dermatol Venereol; 2017 Dec 29; 144(12S):S9-S10. PubMed ID: 29108875
    [No Abstract] [Full Text] [Related]

  • 29. Short version of the German evidence-based Guidelines for prophylactic vaccination against HPV-associated neoplasia.
    Pathirana D, Hillemanns P, Petry KU, Becker N, Brockmeyer NH, Erdmann R, Gissmann L, Grundhewer H, Ikenberg H, Kaufmann AM, Klusmann J, Kopp I, Pfister H, Rzany B, Schneede P, Schneider A, Smola S, Winter-Koch N, Wutzler P, Gross G.
    Vaccine; 2009 Jul 23; 27(34):4551-9. PubMed ID: 19524337
    [Abstract] [Full Text] [Related]

  • 30. [Condyloma typing important for follow up of HPV vaccination. A condyloma reporting project].
    Sturegård E, Johnsson A, Gustafsson E, Dillner J.
    Lakartidningen; 2009 Jul 23; 105(50):3648-50. PubMed ID: 19177930
    [No Abstract] [Full Text] [Related]

  • 31. Cost–effectiveness of catch-up programs in human papillomavirus vaccination.
    de Peuter MA, Littlewood KJ, Annemans L, Largeron N, Quilici S.
    Expert Rev Vaccines; 2010 Oct 23; 9(10):1187-201. PubMed ID: 20923269
    [Abstract] [Full Text] [Related]

  • 32. Factors associated with initiation and completion of human papillomavirus vaccine series among young women enrolled in Medicaid.
    Cook RL, Zhang J, Mullins J, Kauf T, Brumback B, Steingraber H, Mallison C.
    J Adolesc Health; 2010 Dec 23; 47(6):596-9. PubMed ID: 21094437
    [Abstract] [Full Text] [Related]

  • 33. [Preventing cancer: The role of Papillomavirus vaccination in the general population].
    Vié le Sage F, Cohen R.
    Bull Cancer; 2020 Jan 23; 107(1):10-20. PubMed ID: 31982092
    [Abstract] [Full Text] [Related]

  • 34. [Human papillomavirus and cervical cancer: presence and future of vaccination].
    Joura EA.
    Gynakol Geburtshilfliche Rundsch; 2004 Jun 23; 44(3):142-5. PubMed ID: 15211060
    [Abstract] [Full Text] [Related]

  • 35. The new human papillomavirus (HPV) vaccine: pros and cons for pediatric and adolescent health.
    Thomas TL.
    Pediatr Nurs; 2008 Jun 23; 34(5):429-31. PubMed ID: 19051848
    [Abstract] [Full Text] [Related]

  • 36. A summary of the post-licensure surveillance initiatives for GARDASIL/SILGARD.
    Bonanni P, Cohet C, Kjaer SK, Latham NB, Lambert PH, Reisinger K, Haupt RM.
    Vaccine; 2010 Jul 05; 28(30):4719-30. PubMed ID: 20451636
    [Abstract] [Full Text] [Related]

  • 37. [Cervix carcinoma--Austrian Vaccination Committee recommends HPV vaccination].
    Six L, Joura EA.
    Wien Med Wochenschr; 2007 Jul 05; 157(5-6):130-2. PubMed ID: 17427010
    [No Abstract] [Full Text] [Related]

  • 38. Harnessing the power of prevention: human papillomavirus vaccines.
    Mayeaux EJ.
    Curr Opin Obstet Gynecol; 2006 Feb 05; 18 Suppl 1():s15-21. PubMed ID: 16520680
    [Abstract] [Full Text] [Related]

  • 39. Quadrivalent human papillomavirus (HPV) vaccine: a review of safety, efficacy, and pharmacoeconomics.
    Pomfret TC, Gagnon JM, Gilchrist AT.
    J Clin Pharm Ther; 2011 Feb 05; 36(1):1-9. PubMed ID: 21198715
    [Abstract] [Full Text] [Related]

  • 40. Knowledge of human papillomavirus (HPV) and the HPV vaccine in a national sample of Australian men and women.
    Pitts MK, Heywood W, Ryall R, Smith AM, Shelley JM, Richters J, Simpson JM.
    Sex Health; 2010 Sep 05; 7(3):299-303. PubMed ID: 20719218
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.